Last reviewed · How we verify
NCT03952533: ALA
α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D and Risk Factor for Pre-term Birth
NA trial testing Dav in Cervical Shortening in 122 participants. Completed in 1 June 2021.
25 September 2020
Quick facts
| Lead sponsor | University of Modena and Reggio Emilia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 122 |
| Start date | 5 May 2019 |
| Primary completion | 25 September 2020 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Dav
Conditions studied
- Cervical Shortening — all drugs for Cervical Shortening →
- Preterm Birth — all drugs for Preterm Birth →
Sponsor
University of Modena and Reggio Emilia
Who can join
Adults 18 to 41, female only, with Cervical Shortening or Preterm Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Effects of oral administration of a food supplement constituted by α-lipoic acid, magnesium, vitamin B6 and vitamin D in tablets of 1,2 g administered daily to women presenting risk factors for preterm birth (PTB). The aim is to reduce the rate of short cervix at 19-21 weeks of gestational age and consequently reduce the occurrence of PTB.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03952533
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Shortening
Currently open trials in the same condition.
- NCT06884761 — Routine Activity and Preterm Delivery Risk in Women With a Short Cervix · NA · recruiting
Other University of Modena and Reggio Emilia trials
Trials by the same sponsor.
- NCT05282238 — Quantification of Inspiratory Effort Through Nasal Pressure in Patients Undergoing Weaning From Invasive Mechanical Vent · not yet recruiting
- NCT07404423 — OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis · not yet recruiting
- NCT06989385 — CORALINE - Correlation Between Physiological and Clinical Variables and Failure of Non-Invasive Respiratory Support in P · recruiting
- NCT06734949 — CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD · enrolling by invitation
- NCT05043753 — "Fetal gRowth AbnorMality dEtection Trial" · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03952533 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Modena and Reggio Emilia
- Last refreshed: 18 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03952533.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing